Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.48 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | BACE1 | P56817 | 1/20 | 0.43 |
| ▸ | PARP1 | P09874 | 1/20 | 0.43 |
| ▸ | DPP4 | P27487 | 1/20 | 0.42 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.41 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.41 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.41 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | BCAT2 | O15382 | 1/20 | 0.39 |
| ▸ | CASP3 | P42574 | 1/20 | 0.38 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.38 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.38 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.38 |
| ▸ | TDO2 | P48775 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30451343 | 1.00 | ALDH1A1 (0.48) | ALDH1A1HSD17B10HPGDBCL2L1CYP2A6 | |
| Phosphine SCHEMBL28589614 | 0.97 | ALDH1A1 (0.46) | ALDH1A1HSD17B10HPGDBCL2L1CYP2A6 | |
| SCHEMBL6830189 | 0.95 | ALDH1A1 (0.47) | ALDH1A1HSD17B10HPGDBCL2L1CYP2A6 | |
| SCHEMBL7154758 | 0.92 | ALDH1A1 (0.42) | ALDH1A1HSD17B10HPGDBCL2L1CYP2A6 | |
| Iodobenzene SCHEMBL10487194 | 0.92 | ALDH1A1 (0.42) | ALDH1A1HSD17B10HPGDBCL2L1CYP2A6 | |
| Formaldehyde SCHEMBL29276839 | 0.92 | PARP1 (0.43) | ALDH1A1HSD17B10HPGDBCL2L1CYP2A6 | |
| Naphthalene SCHEMBL27789647 | 0.92 | ALDH1A1 (0.42) | ALDH1A1HSD17B10HPGDBCL2L1CYP2A6 | |
| SCHEMBL15484734 | 0.92 | ALDH1A1 (0.46) | ALDH1A1HSD17B10HPGDBCL2L1CYP2A6 | |
| SCHEMBL28848116 | 0.90 | ALDH1A1 (0.41) | ALDH1A1HSD17B10HPGDBCL2L1CYP2A6 | |
| Boric Acid SCHEMBL29225672 | 0.90 | ALDH1A1 (0.46) | ALDH1A1HSD17B10HPGDBCL2L1CYP2A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1313 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119930614-A | Benzo [4,5] imidazo [2,1-a ] isoquinoline compound and preparation method and application thereof | 烟台大学 | 2025-05-06 | — | — | CN | claimed |
| CN-119504330-A | One-step synthesis method of phenanthrene ring aromatic hydrocarbon derivative | 常州大学 | 2025-02-25 | — | — | CN | claimed |
| CN-118637971-A | Synthesis method of 2-methyl-4-phenylindene | 上海毕臣生化科技有限公司 | 2024-09-13 | — | — | CN | claimed |
| CN-116836107-B | Carbazol eight-membered ring large conjugated structure OLED material and preparation method thereof | 西安欧得光电材料有限公司 | 2024-02-27 | — | — | CN | claimed |
| CN-116836107-A | Carbazol eight-membered ring large conjugated structure OLED material and preparation method thereof | 西安欧得光电材料有限公司 | 2023-10-03 | — | — | CN | claimed |
| CN-115745805-A | Synthetic method of phenanthrene and naphthocycloheptene compounds | 南通大学 | 2023-03-07 | — | — | CN | claimed |
| CN-110683926-B | Preparation method of carboxylic acid aryl ester compound | 北京大学深圳研究生院 | 2022-11-04 | — | — | CN | claimed |
| CN-113717018-A | Preparation method of 9-benzylmethylfluorene compound | 温州大学 | 2021-11-30 | — | — | CN | claimed |
| US-20210353631-A1 | 1,4-Benzoxazines for the Treatment of Cancers and Other Neurodegenerative Diseases | Neugeneron LLC | 2021-11-18 | — | — | US | claimed |
| CN-108530241-B | Preparation method of benzo ring derivative with benzyl quaternary carbon center | 武汉大学 | 2021-02-02 | — | — | CN | claimed |
| EP-0377634-B1 | PROCESS FOR THE PREPARATION OF ARYL SULFIDES | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1992-12-02 | — | — | EP | claimed |
| EP-0307446-B1 | LIQUID PHASE ISOMERIZATION OF IODOAROMATIC COMPOUNDS | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1992-06-03 | — | — | EP | claimed |
| EP-0377634-A1 | PROCESS FOR THE PREPARATION OF ARYL SULFIDES. | EASTMAN KODAK CO (US) | 1990-07-18 | — | — | EP | claimed |
| EP-0307458-A1 | PROCESSES FOR ISOMERIZING AND OXIDATIVE IODINATING AROMATIC COMPOUNDS. | EASTMAN KODAK CO (US) | 1989-03-22 | — | — | EP | claimed |
| WO-1989001463-A1 | PROCESS FOR THE PREPARATION OF ARYL SULFIDES | EASTMAN KODAK COMPANY (US) | 1989-02-23 | — | — | WO | claimed |
| US-4806698-A | Liquid phase isomerization of iodoaromatic compounds | EASTMAN KODAK COMPANY (US) | 1989-02-21 | — | — | US | claimed |
| US-4806697-A | NON-ACIDIC ZEOLITE CATALYSTS | EASTMAN KODAK COMPANY (US) | 1989-02-21 | — | — | US | claimed |
| US-4792641-A | Process for preparing iodinated aromatic compounds | EASTMAN KODAK COMPANY (US) | 1988-12-20 | — | — | US | claimed |
| US-4792634-A | HEATING IODOAROMATIC COMPOUND WITH SULFUR | EASTMAN KODAK COMPANY (US) | 1988-12-20 | — | — | US | claimed |
| WO-1988007511-A1 | PROCESSES FOR ISOMERIZING AND OXIDATIVE IODINATING AROMATIC COMPOUNDS | EASTMAN KODAK COMPANY (US) | 1988-10-06 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210353631-A1 | 1,4-Benzoxazines for the Treatment of Cancers and Other Neurodegenerative Diseases | GBA1, NFXL1, CYP4X1 | ALDH1A1 123/4885HSD17B10 879/4885HPGD 320/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.